Netherlands· NL-46417412af44
Monofer 100 mg/ml oplossing voor injectie/infusie
A iron, parenteral preparations product containing ijzer derisomaltose, registered in Netherlands by Pharmacosmos A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ijzer derisomaltose is registered in 11 of 19 countries.
Countries holding a registration under ATC B03AC (iron, parenteral preparations), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Ijzer derisomaltose · ATC B03AC
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- IJZER DERISOMALTOSE
- Manufacturer
- Pharmacosmos A/S
- Country
- Netherlands (NL)
- ATC code
- B03AC
- ATC class
- Iron, parenteral preparations
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id103070
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ijzer derisomaltose in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumDiafer 50 mg/mlPharmacosmos
- SwedenDiafer 50 mg/ml Injektionsvätska, lösningPharmacosmos A/S
- United KingdomDiafer 100mg/2ml solution for injection ampoulesPharmacosmos UK Ltd
- United StatesMonoferricPharmacosmos Therapeutics Inc.
- NorwayDiaferPharmacosmos
- Japanデルイソマルトース第二鉄日本新薬
- PolandDiaferPharmacosmos A/S
- FinlandDiaferPharmacosmos A/S
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Monofer
- Belgium · Monoferric
- Bulgaria · Монофер
- Germany · Monofer
- Denmark · Diafer, Monofer
- Estonia · Monofer
- Finland · Diafer, Monofer
- United Kingdom (Northern Ireland) · Diafer, Monofer
- Croatia · Monofer
- Ireland · Diafer, Monover
- Iceland · Monofer
- Italy · Monoferric
- Lithuania · Monofer
- Luxembourg · Monover
- Latvia · Monofer
- Norway · Diafer, Monofer
- Poland · Diafer, Monover
- Portugal · Monofar
- Romania · Diafer, Monofer
- Sweden · Diafer, Monofer
- Slovenia · Monofer
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c19e63ae-61cb-47b5-9772-899a70100fd2 GET /v1/drugs/c19e63ae-61cb-47b5-9772-899a70100fd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie of infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h103070_smpc.pdf",
"strength": null,
"atc_label": "Iron parenteral preparations",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg103070",
"excipients": [
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"IJZER DERISOMALTOSE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h103070.pdf",
"authorised_at": "2009/12/23",
"procedure_number": "SE/H/0734/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "103070",
"additional_monitoring": "N"
}See everything about ijzer derisomaltose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.